- Nonalcoholic fatty liver disease(NAFLD): fatty infiltration of the liver, exceeding 5% of liver weight. In biopsy specimens, >5-10% macrosteatotic hepatocytes.
- By definition, requires exclusion of alcohol as a potential cause. Acceptable levels of alcohol consumption are controversial but in general < 20 grams/day (2 drinks) in men and < 10 grams/day (1 drink) in women are considered safe, and below the cutoff associated with increased risk of cirrhosis (30 grams/day in men and 20 grams/day in women).
- Primary NAFLD: common term for typical NAFLD associated with central obesity and/or type 2 diabetes (T2DM) or insulin resistance (IR), without another specific etiology.
- Secondary NAFLD: used to defined as NAFLD in the absence of insulin resistance and associated with other causes such as: medication use (glucocorticoids, tamoxifen, amiodarone, HAART, diltiazem), disorders of lipid metabolism (abetalipoproteinemia, lipodystrophy, Weber-Christian syndrome, Andersen’s disease), total parenteral nutrition and jejunoileal bypass surgery. Many cases of "secondary" NAFLD likely represent an exacerbation of often unrecognized "primary" NAFLD.
- Nonalcoholic steatohepatitis (NASH) is the more severe form of NAFLD characterized by inflammation, ballooned hepatocytes, and/or fibrosis on biopsy. NAFLD can progress to cirrhosis.
Nonalcoholic Fatty Liver Disease was found in Johns Hopkins Diabetes Guide.
If you are a registered user, please log in below.
If not, learn more about gaining full access.
- Johns Hopkins Guides include up-to-date, authoritative content to help you treat patients and raise the standard of care.
Try these free topics now!
Johns Hopkins ABX Guide
Johns Hopkins Diabetes Guide
Johns Hopkins HIV Guide